Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-κB signaling pathway

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Zhang, Li ^a   Li, Yuanyuan ^a   Gu, Zhiwen ^a   Wang, Yuyue ^a   Shi, Mei ^a   Ji, Yun ^a   Sun, Jing ^a   Xu, Xiaopeng ^a   Zhang, Lirong ^a   Jiang, Jingtin ^a   Shi, Weifeng ^a  

^a SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; EV71 PROTEIN; I KAPPA B ALPHA; I KAPPA B KINASE; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; POLYDATIN; PROTEIN VP1; RESVERATROL; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN; CYTOKINE; GLUCOSIDE; PICEID; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANTIVIRAL ACTIVITY; ARTICLE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; ENTEROVIRUS 71; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IC50; IN VITRO STUDY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RHABDOMYOSARCOMA CELL; SIGNAL TRANSDUCTION; VIRUS ATTACHMENT; VIRUS REPLICATION; DRUG EFFECTS; ENTEROVIRUS A; INFLAMMATION; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; RHABDOMYOSARCOMA; SECRETION (PROCESS);

HUMAN ENTEROVIRUS 71; POLYGONUM CUSPIDATUM;

ANTIVIRAL AGENTS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENTEROVIRUS A, HUMAN; GLUCOSIDES; I-KAPPA B KINASE; INFLAMMATION; INTERLEUKIN-6; NF-KAPPA B; PHOSPHORYLATION; RHABDOMYOSARCOMA; SIGNAL TRANSDUCTION; STILBENES; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 84923284839     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0116879     Document Type: Article

References (50)

1. Hsu CH, Lu CY, Shao PL, Lee PI, Kao CL, et al. (2011) Epidemiologic and clinical features of non-polio enteroviral infections in northern Taiwan in 2008. J Microbiol Immunol Infect 44:265-273. doi: 10.1016/j.jmii.2011.01.029 PMID: 21524954
2. Irani DN (2008) Aseptic meningitis and viral myelitis. Neurol Clin 26:635-655. doi: 10.1016/j.ncl.2008. 03.003 PMID: 18657719
3. Wu KX, Ng MM-L, Chu JJ (2010) Developments towards antiviral therapies against enterovirus 71. Drug Discov Today 15:1041-1051. doi: 10.1016/j.drudis.2010.10.008 PMID: 20974282
4. Ghanim H, Sia CL, Korzeniewski K, Lohano T, Abuaysheh S, et al. (2011) A resveratrol and polyphenol preparation suppresses oxidative and inflammatory stress response to a high-fat, high-carbohydrate meal. J Clin Endocrinol Metab 96:1409-1414. doi: 10.1210/jc.2010-1812 PMID: 21289251
5. Clouser CL, Chauhan J, Bess MA, Van Oploo JL, Zhou D, et al. (2012) Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine. Bioorg Med Chem Lett 22:6642-6646. doi: 10.1016/j.bmcl.2012.08.108 PMID: 23010273
6. Faith SA, Sweet TJ, Bailey E, Booth T, Docherty JJ (2006) Resveratrol suppresses nuclear factorkappaB in herpes simplex virus infected cells. Antiviral Res 72:242-251. PMID: 16876885
7. Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T (2006) Resveratrol inhibition of varicella-zoster virus replication in vitro. Antiviral Res 72:171-177. PMID: 16899306
8. Evers DL, Wang X, Huong SM, Huang DY, Huang ES (2004) 3, 4', 5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. Antiviral Res 63:85-95. PMID: 15302137
9. Du QH, Peng C, Zhang H (2013) Polydatin: a review of pharmacology and pharmacokinetics. Pharm Biol 51:1347-1354. doi: 10.3109/13880209.2013.792849 PMID: 23862567
10. De Maria S, Scognamiglio I, Lombardi A, Amodio N, Caraglia M, et al. (2013) Polydatin, a natural precursor of resveratrol, induces cell cycle arrest and differentiation of human colorectal Caco-2 cell. J Transl Med 11:264. doi: 10.1186/1479-5876-11-264 PMID: 24138806
11. Chen L, Lan Z, Lin Q, Mi X, He Y, et al. (2013) Polydatin ameliorates renal injury by attenuating oxidative stress-related inflammatory responses in fructose-induced urate nephropathic mice. Food Chem Toxicol 52:28-35. doi: 10.1016/j.fct.2012.10.037 PMID: 23137955
12. Ravagnan G, De Filippis A, Carteni M, De Maria S, Cozza V, et al. (2013) Polydatin, a natural precursor of resveratrol, induces beta-defensin production and reduces inflammatory response. Inflammation 36:26-34. doi: 10.1007/s10753-012-9516-8 PMID: 22956122
13. Cheng Y, Zhang HT, Sun L, Guo S, Ouyang S, et al. (2006) Involvement of cell adhesion molecules in polydatin protection of brain tissues from ischemia-reperfusion injury. Brain Res 1110:193-200. PMID: 16870162
14. Deng YH, Alex D, Huang HQ, Wang N, Yu N, et al. (2011) Inhibition of TNF-alpha-mediated endothelial cell-monocyte cell adhesion and adhesion molecules expression by the resveratrol derivative, trans-3, 5, 4'-trimethoxystilbene. Phytother Res 25:451-457. doi: 10.1002/ptr.3279 PMID: 20740479
15. Heldt CL, Hernandez R, Mudiganti U, Gurgel PV, Brown DT, et al. (2006) A colorimetric assay for viral agents that produce cytopathic effects. J Virol Methods 135:56-65. PMID: 16516983
16. Guo JP, Pang J, Wang XW, Shen ZQ, Jin M, et al. (2006) In vitro screening of traditionally used medicinal plants in China against enteroviruses. World J Gastroenterol 12:4078-4081. PMID: 16810764
17. Mankan AK, Lawless MW, Gray SG, Kelleher D, McManus R (2009) NF-kappaB regulation: the nuclear response. J Cell Mol Med 13:631-643. doi: 10.1111/j.1582-4934.2009.00632.x PMID: 19438970
18. Tung WH, Hsieh HL, Lee IT, Yang CM (2011) Enterovirus 71 modulates a COX-2/PGE2/cAMP-dependent viral replication in human neuroblastoma cells: role of the c-Src/EGFR/p42/p44 MAPK/CREB signaling pathway. J Cell Biochem 112:559-570. doi: 10.1002/jcb.22946 PMID: 21268077
19. Kumar N, Xin ZT, Liang Y, Ly H (2008) NF-kappaB signaling differentially regulates influenza virus RNA synthesis. J Virol 82:9880-9889. doi: 10.1128/JVI.00909-08 PMID: 18701591
20. La Frazia S, Amici C, Santoro MG (2006) Antiviral activity of proteasome inhibitors in herpes simplex virus-1 infection: role of nuclear factor-kappaB. Antivir Ther 11:995-1004. PMID: 17302369
21. Klebl BM, Kurtenbach A, Salassidis K, Daub H, Herget T (2005) Host cell targets in HCV therapy: novel strategy or proven practice? Antivir Chem Chemother 16:69-90. PMID: 15889531
22. Rawlinson SM, Pryor MJ, Wright PJ, Jans DA (2006) Dengue virus RNA polymerase NS5: a potential therapeutic target? Curr Drug Targets 7:1623-1638. PMID: 17168837
23. Zhao Q, Weber E, Yang H (2013) Drug targets for rational design against emerging coronaviruses. Infect Disord Drug Targets 13:116-127. PMID: 23895136
24. Lin TY, Liu YC, Jheng JR, Tsai HP, Jan JT, et al. (2009) Anti-enterovirus 71 activity screening of chinese herbs with anti-infection and inflammation activities. Am J Chin Med 37:143-158. PMID: 19222118
25. Li X, Liu Y, Hou X, Peng H, Zhang L, et al. (2013) Chlorogenic acid inhibits the replication and viability of enterovirus 71 in vitro. PLoS One 8:e76007. doi: 10.1371/journal.pone.0076007 PMID: 24098754
26. Chen X, Wang C, Xu L, Wang W, Yang G, et al. (2013) A laboratory evaluation of medicinal herbs used in china for the treatment of hand, foot, and mouth disease. Evid Based Complement Alternat Med 2013:504563. doi: 10.1155/2013/504563 PMID: 23554831
27. Chu X, Sun A, Liu R (2005) Preparative isolation and purification of five compounds from the Chinese medicinal herb Polygonum cuspidatum Sieb. et Zucc by high-speed counter-current chromatography. J Chromatogr A 1097:33-39. PMID: 16298183
28. Carrizzo A, Forte M, Damato A, Trimarco V, Salzano F, et al. (2013) Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases. Food Chem Toxicol 61:215-226. doi: 10.1016/j.fct. 2013.07.021 PMID: 23872128
29. Kaminski BM, Weigert A, Scherzberg MC, Ley S, Gilbert B, et al. (2014) Resveratrol-induced potentiation of the antitumor effects of oxaliplatin is accompanied by an altered cytokine profile of human monocytederived macrophages. Apoptosis.
30. Augustine N, Goel AK, Sivakumar KC, Ajay Kumar R, Thomas S (2014) Resveratrol-A potential inhibitor of biofilm formation in Vibrio cholerae. Phytomedicine 21:286-289. doi: 10.1016/j.phymed.2013.09. 010 PMID: 24182988
31. Campagna M, Rivas C (2010) Antiviral activity of resveratrol. Biochem Soc Trans 38:50-53. doi: 10. 1042/BST0380050 PMID: 20074034
32. Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, et al. (1999) Resveratrol inhibition of herpes simplex virus replication. Antiviral Res 43:145-155. PMID: 10551373
33. Heredia A, Davis C, Amin MN, Le NM, Wainberg MA, et al. (2014) Targeting host nucleotide biosynthesis with resveratrol inhibits emtricitabine-resistant HIV-1. AIDS 28:317-323. doi: 10.1097/QAD. 0000000000000168 PMID: 24326355
34. Lin HC, Chen YF, Hsu WH, Yang CW, Kao CH, et al. (2012) Resveratrol helps recovery from fatty liver and protects against hepatocellular carcinoma induced by hepatitis B virus X protein in a mouse model. Cancer Prev Res (Phila) 5:952-962. doi: 10.1158/1940-6207. CAPR-12-0001 PMID: 22659145
35. De Leo A, Arena G, Lacanna E, Oliviero G, Colavita F, et al. (2012) Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets. Antiviral Res 96:196-202. doi: 10.1016/j.antiviral.2012.09.003 PMID: 22985630
36. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, et al. (2005) Inhibition of influenza A virus replication by resveratrol. J Infect Dis 191:1719-1729. PMID: 15838800
37. Rivas-Aravena A, Vallejos-Vidal E, Cortez-San Martin M, Reyes-Lopez F, Tello M, et al. (2011) Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection. J Virol 85:8037-8045. doi: 10.1128/JVI.00533-11 PMID: 21653663
38. Bougie I, Bisaillon M (2004) The broad spectrum antiviral nucleoside ribavirin as a substrate for a viral RNA capping enzyme. J Biol Chem 279:22124-22130. PMID: 15037606
39. Ji H, Zhang X, Du Y, Liu H, Li S, et al. (2012) Polydatin modulates inflammation by decreasing NF-kappaB activation and oxidative stress by increasing Gli1, Ptch1, SOD1 expression and ameliorates bloodbrain barrier permeability for its neuroprotective effect in pMCAO rat brain. Brain Res Bull 87:50-59. doi: 10.1016/j.brainresbull.2011.09.021 PMID: 22001340
40. Cui S, Wang J, Fan T, Qin B, Guo L, et al. (2011) Crystal structure of human enterovirus 71 3C protease. J Mol Biol 408:449-461. doi: 10.1016/j.jmb.2011.03.007 PMID: 21396941
41. Han JF, Cao RY, Tian X, Yu M, Qin ED, et al. (2010) Producing infectious enterovirus type 71 in a rapid strategy. Virol J 7:116. doi: 10.1186/1743-422X-7-116 PMID: 20525351
42. Shang L, Xu M, Yin Z (2013) Antiviral drug discovery for the treatment of enterovirus 71 infections. Antiviral Res 97:183-194. doi: 10.1016/j.antiviral.2012.12.005 PMID: 23261847
43. Lanzilli G, Cottarelli A, Nicotera G, Guida S, Ravagnan G, et al. (2012) Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation. Inflammation 35:240-248. doi: 10.1007/s10753-011-9310-z PMID: 21369944
44. Guo R, Li W, Liu B, Li S, Zhang B, et al. (2014) Resveratrol protects vascular smooth muscle cells against high glucose-induced oxidative stress and cell proliferation in vitro. Med Sci Monit Basic Res 20:82-92. doi: 10.12659/MSMBR.890858 PMID: 24971582
45. Liu H, Ren J, Chen H, Huang Y, Li H, et al. (2014) Resveratrol Protects against Cigarette Smoke-Induced Oxidative Damage and Pulmonary Inflammation. J Biochem Mol Toxicol.
46. Zhang HS, Zhou Y, Wu MR, Zhou HS, Xu F (2009) Resveratrol inhibited Tat-induced HIV-1 LTR transactivation via NAD (+)-dependent SIRT1 activity. Life Sci 85:484-489. doi: 10.1016/j.lfs.2009.07.014 PMID: 19664641
47. De Leo A, Arena G, Stecca C, Raciti M, Mattia E (2011) Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program. Mol Cancer Res 9:1346-1355. doi: 10.1158/1541-7786. MCR-11-0145 PMID: 21856773
48. Zhang G, Zhou F, Gu B, Ding C, Feng D, et al. (2012) In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch Virol 157:669-679. doi: 10.1007/s00705-011-1222-6 PMID: 22245989
49. Li ZH, Li CM, Ling P, Shen FH, Chen SH, et al. (2008) Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J Infect Dis 197:854-857. doi: 10.1086/527326 PMID: 18279075
50. Zhang X, Song Z, Qin B, Chen L, Hu Y, et al. (2013) Rupintrivir is a promising candidate for treating severe cases of enterovirus-71 infection: evaluation of antiviral efficacy in a murine infection model. Antiviral Res 97:264-269. doi: 10.1016/j.antiviral.2012.12.029 PMID: 23295352